Literature DB >> 30648540

Thrombolysis Therapy in Specialized and Non-specialized Stroke Units.

Brice Blum1, Leanne Brechtel1, Thomas Nathaniel2.   

Abstract

BACKGROUND: The benefits of a special stroke care unit (SSCU) over a non-specialized stroke care unit (NSSCU) is well documented in the literature. However, there are concerns that the benefits seen in the SSCU do not consider clinical risk factors that affect thrombolysis therapy.
METHOD: Retrospective data were collected from a stroke registry between January 1, 2010-June 30, 2016. Univariate analysis determined differences in exclusion criteria between the SSCU and NSSCU, while multivariable binary logistic regression adjusted for confounding variables. RESULT: Of the 1,446 acute ischemic stroke patients eligible for rtPA, 34.0% of patients were admitted to the NSSCU, while 58.02% were admitted to the SSCU. For patients excluded from receiving rtPA in the SSCU: age >80 (OR = 1.024-1.037, p = <0.001), altered level of consciousness (OR = 1.551-2.363, p = 0.041), risk of mortality (OR = 1.090-1.166, p = 0.012), previous stroke (OR = 1.638-2.338, p = 0.007) were the exclusion criteria from rtPA. In the NSSCU, age >80 (OR = 1.026-1.046, p = 0.012), history of atrial fibrillation (OR = 2.494-4.629, p = 0.004), diabetes (OR = 2.377-5.576, p = 0.047) and previous stroke (OR = 2.782-4.785, p = <0.001) were associated with exclusion from rtPA.
CONCLUSION: More patients are likely to be excluded from rtPA in the NSSCU if they present with history of atrial fibrillation, diabetes, and in the SSCU if they present with altered level of consciousness and are at risk of mortality. Improvement in the management of baseline clinical risk factors would improve thrombolysis use for better patient outcomes in specialized and non specialized stroke units.
Copyright © 2019 IMSS. All rights reserved.

Entities:  

Keywords:  Exclusion criteria; Specialized and non-specialized stroke units; Thrombolytic therapy

Mesh:

Substances:

Year:  2019        PMID: 30648540     DOI: 10.1016/j.arcmed.2019.01.002

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  5 in total

1.  The Association Between an Antecedent of Transient Ischemic Attack Prior to Onset of Stroke and Functional Ambulatory Outcome.

Authors:  Nicolas Poupore; Dan Strat; Tristan Mackey; Thomas I Nathaniel
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

2.  In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy?

Authors:  Oluyemi R Rotimi; Iretioluwa F Ajani; Alexandria Penwell; Shyyon Lari; Brittany Walker; Thomas I Nathaniel
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec

3.  Comorbidities associated with different levels of total cholesterol in male and female acute ischemic stroke patients.

Authors:  Leanne Brechtel; Nicolas Poupore; Teodora Stoikov; Laurie Theriot Roley; John F Emerson; Thomas Nathaniel
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.889

4.  Obstructive sleep apnea and stroke severity: Impact of clinical risk factors.

Authors:  Carolyn Breauna Sanders; Krista Knisely; Camron Edrissi; Chase Rathfoot; Nicolas Poupore; Leah Wormack; Thomas Nathaniel
Journal:  Brain Circ       Date:  2021-05-29

5.  Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients.

Authors:  Nicolas Poupore; Dan Strat; Tristan Mackey; Katherine Brown; Ashley Snell; Thomas I Nathaniel
Journal:  Lipids Health Dis       Date:  2020-05-06       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.